Clinical trials
Completed trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19,267 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 141 |
| 2001 | 203 |
| 2002 | 295 |
| 2003 | 393 |
| 2004 | 485 |
| 2005 | 687 |
| 2006 | 735 |
| 2007 | 760 |
| 2008 | 873 |
| 2009 | 828 |
| 2010 | 893 |
| 2011 | 963 |
| 2012 | 1,020 |
| 2013 | 1,031 |
| 2014 | 1,040 |
| 2015 | 1,067 |
| 2016 | 1,022 |
| 2017 | 1,111 |
| 2018 | 1,065 |
| 2019 | 930 |
| 2020 | 697 |
| 2021 | 877 |
| 2022 | 691 |
| 2023 | 540 |
| 2024 | 328 |
| 2025 | 157 |
| 2026 | 33 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19,267 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 701 |
| University of British Columbia | 671 |
| University of Alberta | 478 |
| Novartis Pharmaceuticals | 384 |
| McMaster University | 383 |
| GlaxoSmithKline | 366 |
| The Hospital for Sick Children | 339 |
| Pfizer | 335 |
| Hoffmann-La Roche | 333 |
| AstraZeneca | 321 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 541 |
| Breast Neoplasms | 470 |
| Neoplasms | 439 |
| Prostatic Neoplasms | 338 |
| Obesity | 324 |
| Diabetes Mellitus | 317 |
| Asthma | 294 |
| Carcinoma, Non-Small-Cell Lung | 287 |
| Pulmonary Disease, Chronic Obstructive | 283 |
| Pain | 269 |
Trials
Showing 51 to 75 of 19,267. Each trial links to its page on Pharma Observatory.
19,167 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.